Varaico: Literature-Extracted Genetic Variants

Gene:RYR1
Variant:p.G4899R
Back to variants list

RYR1

NM_000540.3:p.G4899R

Associated Papers

Complementary Roles of Structure and Variant Effect Predictors in RyR1 Clinical Interpretation.

Hernández Trapero R et al.

Human Mutation, 2025

41080992 (PubMed )
Supplement: 1834898.f6.xlsx › Missense_Variants

Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies.

Rossi D et al.

The Journal of General Physiology, 2022

Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study.

Fusto A et al.

Acta Neuropathologica Communications, 2022

Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Lawal TA et al.

Orphanet Journal of Rare Diseases, 2020

Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.

Sato K et al.

Anesthesiology, 2010

Ryanodine receptor as a new therapeutic target of heart failure and lethal arrhythmia.

Yano M

Circulation Journal : Official Journal of the Japanese Circulation Society, 2008

Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies.

Xu L et al.

The Journal of Biological Chemistry, 2008

Diseases associated with altered ryanodine receptor activity.

Durham WJ et al.

Sub-cellular Biochemistry, 2007

Mutations in RYR1 in malignant hyperthermia and central core disease.

Robinson R et al.

Human Mutation, 2006

Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia.

Yano M et al.

Nature Clinical Practice. Cardiovascular Medicine, 2006

Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders.

Treves S et al.

Neuromuscular Disorders : Nmd, 2005

Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population.

Sambuughin N et al.

Anesthesiology, 2005

Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.

Avila G

Cell Calcium, 2005

111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9-11 November 2002, Naarden, The Netherlands.

Jungbluth H et al.

Neuromuscular Disorders : Nmd, 2004

Malignant hyperthermia in North America: genetic screening of the three hot spots in the type I ryanodine receptor gene.

Sei Y et al.

Anesthesiology, 2004

The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.

Avila G et al.

The Journal of General Physiology, 2003

Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.

Tilgen N et al.

Human Molecular Genetics, 2001

Diagnostics in skeletal muscle channelopathies.

Vicino A et al.

Expert Review of Molecular Diagnostics, 0

[Peranesthetic familial malignant hyperthermia].

Joannard A

Pediatrie, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."